In the BioHarmony Drug Report Database

"Preview" Icon

Cyclothiazide

Anhydron, Fluidil (cyclothiazide) is a small molecule pharmaceutical. Cyclothiazide was first approved as Anhydron on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. The pharmaceutical is active against solute carrier family 12 member 3. In addition, it is known to target glutamate receptor 1, glutamate receptor 2, glutamate receptor 3, and glutamate receptor 4.

 

Trade Name

 

Anhydron, Fluidil
 

Common Name

 

cyclothiazide
 

ChEMBL ID

 

CHEMBL61593
 

Indication

 

edema, heart failure, hypertension, nephrotic syndrome
 

Drug Class

 

Diuretics (thiazide derivatives)

Image (chem structure or protein)

Cyclothiazide structure rendering